Lucira Health Inc

NASDAQ:LHDX   3:59:50 PM EDT
5.90
+0.03 (+0.51%)
Products

Lucira Health Inc Provides Statement On Copan’S Recall Of Its FLOQSwabs

Published: 10/08/2021 10:09 GMT
Lucira Health Inc (LHDX) - Lucira™ Health Provides Statement on Copan’s Recall of Its Floqswabs.
Lucira Health Inc - Estimates Expenses Related to Recalled Copan Swabs to Be Between $75,000 and $85,000.
Lucira Health Inc - Intends to Pass-through All Related Expenses, Including But Not Limited to Third Party and Legal Costs, to Copan.
Lucira Health Inc - Recalled Copan Swabs Had No Impact on Revenue Recorded During Distribution Period.